Best ozone therapy for immune support: An evidence and safety review

The question of the best ozone therapy for immune support requires a distinction between proposed immune modulation and proven clinical benefit. Medical ozone has been studied through several delivery methods, but available evidence remains inconsistent, and ozone is not approved by the U.S. Food and Drug Administration for treating a specific disease or condition. 3 4

What ozone therapy is intended to do

Medical ozone is a reactive gas produced from medical-grade oxygen and used in controlled clinical protocols. Reviews describe its biological action as a carefully dosed oxidative stimulus that may affect redox signaling, antioxidant defenses, inflammatory cytokines, and immune-cell activity. These mechanisms support the term “immunomodulator,” rather than the simpler claim that ozone universally “boosts” immunity. 1 2 9

The proposed response is sometimes described as hormesis: a limited oxidative challenge may activate protective systems such as nuclear factor erythroid 2-related factor 2, glutathione, catalase, and superoxide dismutase. Mechanistic reviews also discuss possible effects on macrophages, cytokine signaling, natural killer cells, and T-cell balance. However, biochemical plausibility does not establish that a person will experience fewer infections or better immune outcomes. 2 9

Major autohemotherapy and systemic delivery

Major autohemotherapy, commonly abbreviated MAH, is described as a primary systemic method. Blood is withdrawn, exposed to a measured ozone-oxygen mixture outside the body, and then returned through an intravenous line. The method differs fundamentally from injecting ozone gas directly into a vein, because the gas is handled outside the bloodstream before the blood is reinfused. 5 7

Among the methods discussed for systemic immune support, MAH has the most recognizable clinical literature and is frequently presented as the leading systemic approach. That status does not mean it is established as the best treatment for immune health. Evidence reviews characterize the clinical research as limited, with small or inconsistent studies and too few large, high-quality randomized trials to confirm broad immune benefits. 1 8

Rectal insufflation and other routes

Rectal insufflation introduces ozone through the rectum and is described in the research payload as a non-intravenous route studied for systemic absorption. It may be considered when clinicians seek a route that does not require blood withdrawal or venous access. The existence of studies on this method does not demonstrate equivalence to MAH, and comparative evidence for immune outcomes is not established in the supplied material. 6

Other practices include topical ozone, ozonated fluids, minor autohemotherapy, ultraviolet blood irradiation, and injections directed at particular tissues. These approaches have different exposure pathways and clinical purposes, so their results cannot automatically be generalized to immune support. Direct intravenous ozone gas injection should be avoided because the supplied clinical safety information identifies a risk of pulmonary embolism and potentially fatal air embolism. 3 7

What the clinical evidence shows

Research reviews report that ozone has antimicrobial activity against bacteria, viruses, and fungi in laboratory settings, while clinical investigations have explored chronic infections, diabetic complications, wound healing, pain, and post-viral symptoms. These areas do not amount to proof that ozone prevents ordinary infections or corrects an immune deficiency. Clinical relevance depends on the condition, protocol, comparator, dose, and outcome measured. 1 3

The strongest limitation is the gap between mechanism and patient-centered evidence. A narrative review can summarize pathways and published clinical observations, but it cannot substitute for adequately controlled trials. The supplied research specifically notes that high-quality clinical evidence remains limited, while WebMD reports no good scientific evidence supporting many proposed uses. Claims of broad immune enhancement should therefore be treated as unconfirmed rather than as established medical outcomes. 3 8

Safety, eligibility, and regulatory issues

Ozone is a powerful oxidizing agent, and inhalation is considered unsafe because it can harm the lungs. Regulatory information supplied for this review states that the FDA characterizes ozone as a toxic gas with no known useful medical application. This regulatory position contrasts with use in some European and Asian integrative practices, creating an important distinction between availability in a setting and approval for a particular medical indication. 3 4

Safety assessment should include the delivery route, equipment, sterile handling, clinician training, and the patient’s medical history. The supplied clinical material lists G6PD deficiency, thrombocytopenia, active hyperthyroidism, and pregnancy among situations requiring exclusion or particular caution. Reported adverse experiences can include fatigue, localized inflammation, and Herxheimer-type reactions. These risks make unsupervised or direct gas administration inappropriate. 6 3

How to interpret the “best” option

No supplied source establishes one ozone method as the universally best choice for immune support. MAH is the most frequently described systemic technique, while rectal insufflation is a studied alternative that avoids venous blood handling. The relevant comparison is not simply which method sounds more intensive, but whether a proposed indication has credible human evidence, whether risks have been assessed, and whether the treatment has a defined clinical endpoint. 5 6 8

A responsible evaluation should distinguish immune modulation from treatment of an identified immunodeficiency, infection, autoimmune disease, or inflammatory disorder. Questions about diagnosis, objective outcome measures, contraindications, informed consent, and conventional care are more useful than promises of generalized immune strengthening. On the current evidence supplied, ozone therapy is best regarded as an investigational or adjunctive practice, not a replacement for established evaluation and treatment. 1 2 4

Sources

1. Frontiers in Medicine, “Medical ozone: mechanisms, biological effects and clinical evidence,” https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1859221/full
2. MDPI, “Ozone as an Immunomodulator: New Therapeutic Possibilities in the Treatment of Immunodeficiencies,” https://www.mdpi.com/1467-3045/47/12/1016
3. WebMD, “Ozone Therapy: Uses, Side Effects, and More,” https://www.webmd.com/vitamins/ai/ingredientmono-1233/ozone-therapy
4. U.S. Food and Drug Administration, “FDA Reminds Public: Ozone Is a Toxic Gas, Not a Medical Treatment,” https://www.fda.gov/news-events/press-announcements/fda-reminds-public-ozone-is-toxic-gas-not-medical-treatment
5. National Center for Biotechnology Information, discussion of major autohemotherapy, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312702/
6. Journal of Natural Science, Biology and Medicine, discussion of rectal insufflation, https://www.jnsbm.org/article.asp?issn=0976-9668;year=2011;volume=2;issue=1;spage=66;epage=70;aulast=Bocci
7. Cleveland Clinic, “Ozone Therapy,” https://my.clevelandclinic.org/health/treatments/25134-ozone-therapy
8. Scientific Reports, clinical evidence discussion, https://www.nature.com/articles/s41598-020-74526-7
9. Frontiers in Physiology, discussion of oxidative stress and adaptive responses, https://www.frontiersin.org/articles/10.3389/fphys.2018.00672/full